LONDON–(BUSINESS WIRE)–Jan 29, 2021–
The influenza diagnostics market is poised to grow by $ 1.32 bn during 2020-2024, decelerating at a CAGR of almost 10% during the forecast period.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210129005444/en/
Technavio has announced its latest market research report titled Global Influenza Diagnostics Market 2020-2024 (Graphic: Business Wire).
Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.
Get FREE Sample Report in Minutes!
The report on the influenza diagnostics market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by growing demand for POCT.
The influenza diagnostics market analysis includes end-user segment and geography landscape. This study identifies the rising approvals for influenza diagnostic products as one of the prime reasons driving the influenza diagnostics market growth during the next few years.
This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The influenza diagnostics market covers the following areas:
Influenza Diagnostics Market Sizing
Influenza Diagnostics Market Forecast
Influenza Diagnostics Market Analysis
Companies Mentioned
- Abbott Laboratories
- Biocartis Group NV
- Bio-Rad Laboratories Inc.
- Danaher Corp.
- DiaSorin Spa
- GenMark Diagnostics Inc.
- Meridian Bioscience Inc.
- Quidel Corp.
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
Related Reports on Health Care Include:
- Microarray Biochips Market by Application and Geography – Forecast and Analysis 2020-2024- The microarray biochips market size has the potential to grow by USD 10.22 billion during 2020-2024, and the market’s growth momentum will accelerate at a CAGR of 19.84%. To get extensive research insights: Click and get FREE sample report in minutes
- Proteomics Market by Product, Application, and Geography – Forecast and Analysis 2020-2024 – The proteomics market size has the potential to grow by USD 15.82 billion during 2020-2024, and the market’s growth momentum will accelerate at a CAGR of 13.73%. To get extensive research insights: Click and get FREE sample report in minutes
Key Topics Covered:
Executive Summary
Market Landscape
- Market ecosystem
- Market characteristics
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 – 2024
Five Forces Analysis
- Five Forces Summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by End-user
- Market segments
- Comparison by End-user
- Hospitals and diagnostic laboratories – Market size and forecast 2019-2024
- Academic and research centers – Market size and forecast 2019-2024
- Home care – Market size and forecast 2019-2024
- Market opportunity by End-user
Market Segmentation by Type
- Market segments
- Comparison by Type
- Point-of-care testing – Market size and forecast 2019-2024
- Immunodiagnostics – Market size and forecast 2019-2024
- Molecular diagnostics – Market size and forecast 2019-2024
- Market opportunity by Type
Customer Landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America – Market size and forecast 2019-2024
- Europe – Market size and forecast 2019-2024
- Asia – Market size and forecast 2019-2024
- ROW – Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Vendor landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Abbott Laboratories
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- Danaher Corp.
- F. Hoffmann-La Roche Ltd.
- Hologic Inc.
- Quidel Corp.
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio’s SUBSCRIPTION platform
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com:https://www.businesswire.com/news/home/20210129005444/en/
CONTACT: Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email:[email protected]
Website:www.technavio.com/
KEYWORD:
INDUSTRY KEYWORD: INFECTIOUS DISEASES HEALTH MEDICAL SUPPLIES
SOURCE: Technavio Research
Copyright Business Wire 2021.
PUB: 01/29/2021 11:19 AM/DISC: 01/29/2021 11:19 AM
http://www.businesswire.com/news/home/20210129005444/en
